Variable | N (ntotal = 446) | % |
---|---|---|
Gender | 446 | 100 |
Female | 120 | 26.9 |
Male | 326 | 73.1 |
Age in years (Mean ± SD) | 62.4 ± 11.9 | |
≤ 30 | 6 | 1.3 |
31–45 | 22 | 4.9 |
46–65 | 243 | 54.5 |
66–75 | 109 | 24.4 |
> 75 | 66 | 14.8 |
Marital status | 436 | 97.8 |
Single | 55 | 12.3 |
Married | 298 | 66.8 |
Permanent partnership | 13 | 2.9 |
Divorced | 35 | 7.8 |
Widowed | 35 | 7.8 |
Educational level | 243 | 54.5 |
Non-academic | 195 | 43.7 |
Academic | 48 | 10.8 |
Comorbidities | 446 | |
None | 95 | 21.0 |
At least one comorbidity | 351 | 79.0 |
Cardiovascular comorbidity | 176 | 39.6 |
Pulmonal comorbidity | 63 | 14.2 |
Neurological comorbidity | 47 | 10.6 |
Oncological comorbidity | 99 | 22.3 |
Regular medication | 401 | 89.9 |
Yes | 287 | 64.3 |
No | 114 | 25.6 |
Living Environment | 411 | 92.2 |
Independent at home | 357 | 80.0 |
At home with support | 49 | 11.0 |
Care facility | 5 | 1.2 |
Religion | 413 | 92.6 |
Protestant | 182 | 40.8 |
Roman-catholic | 173 | 38.8 |
Muslim | 5 | 1.1 |
Other religion | 27 | 6.5 |
Atheist | 26 | 5.8 |
Religiosity | 413 | 92.6 |
Yes | 387 | 86.8 |
No | 26 | 5.8 |
Cancer location | 446 | 100 |
Oral cavity & oropharynx | 147 | 33.0 |
Hypopharynx & larynx | 116 | 26.0 |
Nose & nasopharynx | 34 | 7.6 |
Salivary glands | 61 | 13.7 |
Other head and neck cancer entities | 72 | 16.1 |
Multi-tier carcinoma | 16 | 3.6 |
Secondary malignanciesa | 432 | 96.9 |
No | 360 | 80.7 |
Yes, synchronous | 18 | 4.0 |
Yes, metachronous | 54 | 12.2 |
Recurrence of cancer | 437 | 98.0 |
No | 395 | 88.6 |
Loco-regional recurrence | 39 | 8.7 |
Distant metastases | 3 | 0.7 |
UICC stadium | 385 | 86.3 |
0 | 6 | 1.3 |
I | 132 | 29.6 |
II | 67 | 15.0 |
III | 61 | 13.7 |
IV | 119 | 26.7 |
ECOG performance status | 386 | 86.5 |
0 | 289 | 64.8 |
1 | 74 | 16.6 |
2 | 21 | 4.7 |
3 | 2 | 0.4 |
Applied therapy | 446 | 100 |
Surgery | 171 | 38.3 |
Primary surgery plus adjuvant therapy | 71 | 15.9 |
Definitive radiochemotherapy | 198 | 44.4 |
Salvage surgery | 6 | 1.3 |
Time between initial diagnosis and survey period | ||
0–12 months | 113 | 25.3 |
13–60 months | 178 | 39.9 |
61–120 months | 92 | 20.6 |
120+ months | 63 | 14.1 |